Cargando…

Prevalence, Pharmacological Treatment, and Control of Cardiometabolic Risk Factors among Older People in Central Stockholm: A Population-Based Study

BACKGROUND: Cardiometabolic risk factors and related cardiovascular diseases represent major threats to healthy aging. OBJECTIVE: We aimed to estimate distribution, pharmacological treatment, and control of main cardiometabolic risk factors among older people. METHODS: This population-based study in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Rui, Fratiglioni, Laura, Liang, Yajun, Welmer, Anna-Karin, Xu, Weili, Mangialasche, Francesca, Johnell, Kristina, Qiu, Chengxuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370718/
https://www.ncbi.nlm.nih.gov/pubmed/25799502
http://dx.doi.org/10.1371/journal.pone.0119582
_version_ 1782362924446121984
author Wang, Rui
Fratiglioni, Laura
Liang, Yajun
Welmer, Anna-Karin
Xu, Weili
Mangialasche, Francesca
Johnell, Kristina
Qiu, Chengxuan
author_facet Wang, Rui
Fratiglioni, Laura
Liang, Yajun
Welmer, Anna-Karin
Xu, Weili
Mangialasche, Francesca
Johnell, Kristina
Qiu, Chengxuan
author_sort Wang, Rui
collection PubMed
description BACKGROUND: Cardiometabolic risk factors and related cardiovascular diseases represent major threats to healthy aging. OBJECTIVE: We aimed to estimate distribution, pharmacological treatment, and control of main cardiometabolic risk factors among older people. METHODS: This population-based study included 3363 participants (age≥60 years, 64.9% women) in the Swedish National study on Aging and Care in Kungsholmen, in central Stockholm, Sweden (2001-2004). Data on demographics, cardiometabolic risk factors (hypertension, obesity, diabetes, and high cholesterol), and medication use were collected through face-to-face interviews, clinical examinations, laboratory tests, and the inpatient register. Cardiometabolic risk factors were defined following the most commonly used criteria. Prevalence was standardized using local census data. RESULTS: The age- and sex-standardized prevalence of diabetes, obesity, high cholesterol, and hypertension was 9.5%, 12.8%, 49.7%, and 74.9%, respectively. The prevalence of hypertension and diabetes increased with age, whereas the prevalence of obesity and high cholesterol decreased with age. Forty-nine percent of older adults had two or more cardiometabolic risk factors; 9.8% had three or more. Overall, 55.5% of people with hypertension, 50.3% with diabetes, and 25.0% with high cholesterol received pharmacological treatment. Of those treated pharmacologically, 49.4%, 38.1%, and 85.5% reached therapeutic goals for hypertension (blood pressure<150/90 mmHg), diabetes (glycated haemoglobin<7%), and high cholesterol (total cholesterol<6.22 mmol/l), respectively. CONCLUSIONS: Hypertension, high cholesterol, and clustering of cardiometabolic risk factors were common among older people in Stockholm, but pharmacological treatment and control of these major factors can be improved. Appropriate management of cardiometabolic profiles among older people may help improve cardiovascular health and achieve healthy aging.
format Online
Article
Text
id pubmed-4370718
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43707182015-04-04 Prevalence, Pharmacological Treatment, and Control of Cardiometabolic Risk Factors among Older People in Central Stockholm: A Population-Based Study Wang, Rui Fratiglioni, Laura Liang, Yajun Welmer, Anna-Karin Xu, Weili Mangialasche, Francesca Johnell, Kristina Qiu, Chengxuan PLoS One Research Article BACKGROUND: Cardiometabolic risk factors and related cardiovascular diseases represent major threats to healthy aging. OBJECTIVE: We aimed to estimate distribution, pharmacological treatment, and control of main cardiometabolic risk factors among older people. METHODS: This population-based study included 3363 participants (age≥60 years, 64.9% women) in the Swedish National study on Aging and Care in Kungsholmen, in central Stockholm, Sweden (2001-2004). Data on demographics, cardiometabolic risk factors (hypertension, obesity, diabetes, and high cholesterol), and medication use were collected through face-to-face interviews, clinical examinations, laboratory tests, and the inpatient register. Cardiometabolic risk factors were defined following the most commonly used criteria. Prevalence was standardized using local census data. RESULTS: The age- and sex-standardized prevalence of diabetes, obesity, high cholesterol, and hypertension was 9.5%, 12.8%, 49.7%, and 74.9%, respectively. The prevalence of hypertension and diabetes increased with age, whereas the prevalence of obesity and high cholesterol decreased with age. Forty-nine percent of older adults had two or more cardiometabolic risk factors; 9.8% had three or more. Overall, 55.5% of people with hypertension, 50.3% with diabetes, and 25.0% with high cholesterol received pharmacological treatment. Of those treated pharmacologically, 49.4%, 38.1%, and 85.5% reached therapeutic goals for hypertension (blood pressure<150/90 mmHg), diabetes (glycated haemoglobin<7%), and high cholesterol (total cholesterol<6.22 mmol/l), respectively. CONCLUSIONS: Hypertension, high cholesterol, and clustering of cardiometabolic risk factors were common among older people in Stockholm, but pharmacological treatment and control of these major factors can be improved. Appropriate management of cardiometabolic profiles among older people may help improve cardiovascular health and achieve healthy aging. Public Library of Science 2015-03-23 /pmc/articles/PMC4370718/ /pubmed/25799502 http://dx.doi.org/10.1371/journal.pone.0119582 Text en © 2015 Wang et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Wang, Rui
Fratiglioni, Laura
Liang, Yajun
Welmer, Anna-Karin
Xu, Weili
Mangialasche, Francesca
Johnell, Kristina
Qiu, Chengxuan
Prevalence, Pharmacological Treatment, and Control of Cardiometabolic Risk Factors among Older People in Central Stockholm: A Population-Based Study
title Prevalence, Pharmacological Treatment, and Control of Cardiometabolic Risk Factors among Older People in Central Stockholm: A Population-Based Study
title_full Prevalence, Pharmacological Treatment, and Control of Cardiometabolic Risk Factors among Older People in Central Stockholm: A Population-Based Study
title_fullStr Prevalence, Pharmacological Treatment, and Control of Cardiometabolic Risk Factors among Older People in Central Stockholm: A Population-Based Study
title_full_unstemmed Prevalence, Pharmacological Treatment, and Control of Cardiometabolic Risk Factors among Older People in Central Stockholm: A Population-Based Study
title_short Prevalence, Pharmacological Treatment, and Control of Cardiometabolic Risk Factors among Older People in Central Stockholm: A Population-Based Study
title_sort prevalence, pharmacological treatment, and control of cardiometabolic risk factors among older people in central stockholm: a population-based study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370718/
https://www.ncbi.nlm.nih.gov/pubmed/25799502
http://dx.doi.org/10.1371/journal.pone.0119582
work_keys_str_mv AT wangrui prevalencepharmacologicaltreatmentandcontrolofcardiometabolicriskfactorsamongolderpeopleincentralstockholmapopulationbasedstudy
AT fratiglionilaura prevalencepharmacologicaltreatmentandcontrolofcardiometabolicriskfactorsamongolderpeopleincentralstockholmapopulationbasedstudy
AT liangyajun prevalencepharmacologicaltreatmentandcontrolofcardiometabolicriskfactorsamongolderpeopleincentralstockholmapopulationbasedstudy
AT welmerannakarin prevalencepharmacologicaltreatmentandcontrolofcardiometabolicriskfactorsamongolderpeopleincentralstockholmapopulationbasedstudy
AT xuweili prevalencepharmacologicaltreatmentandcontrolofcardiometabolicriskfactorsamongolderpeopleincentralstockholmapopulationbasedstudy
AT mangialaschefrancesca prevalencepharmacologicaltreatmentandcontrolofcardiometabolicriskfactorsamongolderpeopleincentralstockholmapopulationbasedstudy
AT johnellkristina prevalencepharmacologicaltreatmentandcontrolofcardiometabolicriskfactorsamongolderpeopleincentralstockholmapopulationbasedstudy
AT qiuchengxuan prevalencepharmacologicaltreatmentandcontrolofcardiometabolicriskfactorsamongolderpeopleincentralstockholmapopulationbasedstudy